$FIVE
FIVE BELOW, INC Stock $five

$five Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000117760923000028 Filed on November 30, 2023

Income Statement

Concept	2023 Q4
Revenue	$736.4M
YoY Change	14.17%
Cost Of Revenue	$513.6M
YoY Change	17.46%
Gross Profit	$222.8M
YoY Change	7.23%
Gross Profit Margin	30.26%
Selling, General & Admin	$206.7M
YoY Change	10.61%
% of Gross Profit	92.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$33.55M
YoY Change	21.66%
% of Gross Profit	15.06%
Operating Expenses	$206.7M
YoY Change	10.61%
Operating Profit	$16.12M
YoY Change	-22.98%
Interest Expense	$3.434M
YoY Change	610.97%
% of Operating Profit	21.3%
Other Income/Expense, Net
YoY Change
Pretax Income	$19.56M
YoY Change	-8.68%
Income Tax	$4.963M
% Of Pretax Income	25.38%
Net Earnings	$14.59M
YoY Change	-9.61%
Net Earnings / Revenue	1.98%
Basic Earnings Per Share	$0.26
Diluted Earnings Per Share	$0.26
COMMON SHARES
Basic Shares Outstanding	55.45M shares
Diluted Shares Outstanding	55.58M shares

Balance Sheet

Concept	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$162.9M
YoY Change	39.31%
Cash & Equivalents	$162.9M
Short-Term Investments	$0.00
Other Short-Term Assets	$109.7M
YoY Change	28.3%
Inventory	$763.3M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.091B
YoY Change	14.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.075B
YoY Change	22.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$16.07M
YoY Change	16.77%
Total Long-Term Assets	$2.566B
YoY Change	16.3%
TOTAL ASSETS
Total Short-Term Assets	$1.091B
Total Long-Term Assets	$2.566B
Total Assets	$3.657B
YoY Change	15.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$349.3M
YoY Change	24.84%
Accrued Expenses	$158.3M
YoY Change	3.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$758.2M
YoY Change	18.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$1.460B
YoY Change	12.48%
Total Long-Term Liabilities	$1.460B
YoY Change	12.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$758.2M
Total Long-Term Liabilities	$1.460B
Total Liabilities	$2.280B
YoY Change	15.17%
SHAREHOLDERS EQUITY
Retained Earnings	$1.199B
YoY Change	29.08%
Common Stock	$178.4M
YoY Change	-30.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.378B
YoY Change
Total Liabilities & Shareholders Equity	$3.657B
YoY Change	15.61%

Cashflow Statement

Concept	2023 Q4
OPERATING ACTIVITIES
Net Income	$14.59M
YoY Change	-9.61%
Depreciation, Depletion And Amortization	$33.55M
YoY Change	21.66%
Cash From Operating Activities	-$77.41M
YoY Change	-15.06%
INVESTING ACTIVITIES
Capital Expenditures	$115.5M
YoY Change	-280.84%
Acquisitions
YoY Change
Other Investing Activities	$101.8M
YoY Change	128.39%
Cash From Investing Activities	-$13.68M
YoY Change	-29.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-80.51M
YoY Change	17910.74%
NET CHANGE
Cash From Operating Activities	-77.41M
Cash From Investing Activities	-13.68M
Cash From Financing Activities	-80.51M
Net Change In Cash	-171.6M
YoY Change	54.77%
FREE CASH FLOW
Cash From Operating Activities	-$77.41M
Capital Expenditures	$115.5M
Free Cash Flow	-$192.9M
YoY Change	607.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13761000	usd
CY2023Q1	us-gaap	Assets Assets	3324911000	usd
CY2022Q4	us-gaap	Assets Assets	3163715000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	349340000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	221120000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	279836000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	19928000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19357000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	25420000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14140000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	158272000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	136316000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	152260000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	231197000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	193614000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	758166000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	602560000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	639850000	usd
CY2023Q4	five	Deferred Rent Credit And Other Noncurrent DeferredRentCreditAndOtherNoncurrent	4625000	usd
CY2023Q1	five	Deferred Rent Credit And Other Noncurrent DeferredRentCreditAndOtherNoncurrent	4296000	usd
CY2022Q4	five	Deferred Rent Credit And Other Noncurrent DeferredRentCreditAndOtherNoncurrent	4307000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1455358000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1296975000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2279513000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1962982000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1979227000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55537221	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55537221	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	551000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	555000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	555000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	177877000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	260784000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	254663000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1199497000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1100590000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	929270000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1377925000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1361929000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1184488000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	523820000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	16123000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	20934000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	117129000	usd
CY2023Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3434000	usd
CY2022Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	483000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	11423000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19557000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21417000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	128552000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4963000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5271000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29645000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	14594000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	16146000	usd
	us-gaap	Net Income Loss NetIncomeLoss	98907000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.78
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.78
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55452533	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55509525	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55592536	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55576140	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55683609	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55717987	shares
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3624000	usd
CY2023Q2	five	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	24000	usd
CY2023Q2	five	Common Shares Withheld CommonSharesWithheld	15868000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	37478000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1387301000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5713000	usd
CY2023Q3	five	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	28000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	440000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	46835000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1440146000	usd
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	0	shares
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	199776000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1293692000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	61364000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	59151000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	41378000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55192500	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55192500	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55512425	shares
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3657438000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3324911000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3163715000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	736405000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	645034000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2221633000	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	513577000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	222828000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	207808000	usd
	us-gaap	Gross Profit GrossProfit	722211000	usd
	us-gaap	Gross Profit GrossProfit	643094000	usd
CY2023Q3	five	Common Shares Withheld CommonSharesWithheld	283000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3599000	usd
CY2023Q4	five	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	234000	usd
CY2023Q4	five	Common Shares Withheld CommonSharesWithheld	244000	usd
CY2023Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	80541000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	14594000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1377925000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1120284000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5857000	usd
CY2022Q2	five	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	79000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000	usd
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	40007000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	32718000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1114942000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6007000	usd
CY2022Q3	five	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	22000	usd
CY2022Q3	five	Common Shares Withheld CommonSharesWithheld	314000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	464000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	41344000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1162581000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	158000	usd
CY2022Q4	five	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	9000	usd
CY2022Q4	five	Common Shares Withheld CommonSharesWithheld	208000	usd
	us-gaap	Net Income Loss NetIncomeLoss	90208000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76698000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18117000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5222000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	364000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	246457000	usd
	five	Increase Decrease Prepaid Income Tax IncreaseDecreasePrepaidIncomeTax	14064000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	21787000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	79046000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-28096000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-39399000	usd
	five	Increase Decrease In Operating Leases IncreaseDecreaseInOperatingLeases	-27271000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	7895000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44982000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	31815000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	273951000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	173589000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	68547000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	248000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	440000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	464000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	80541000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	40007000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	288000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	111000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	16395000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4629000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-96208000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-44309000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-169396000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20744000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64973000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	162928000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44229000	usd
	five	Increase Decrease In Capital Expenditures Incurred But Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid	11541000	usd
	five	Increase Decrease In Capital Expenditures Incurred But Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid	6008000	usd
CY2023Q4	five	Products Offering Price ProductsOfferingPrice	5	usd
CY2023Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	43	state
CY2023Q4	five	Number Of Company Operated Stores NumberOfCompanyOperatedStores	1481	stores
CY2022Q4	five	Number Of Company Operated Stores NumberOfCompanyOperatedStores	1292	stores
	us-gaap	Fiscal Period FiscalPeriod	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Fiscal Year</span>The Company operates on a 52/53-week fiscal year ending on the Saturday closest to January 31. References to "fiscal year 2023" or "fiscal 2023" refer to the period from January 29, 2023 to February 3, 2024, which is a 53-week fiscal year. References to "fiscal year 2022" or "fiscal 2022" refer to the period from January 30, 2022 to January 28, 2023, which is a 52-week fiscal year. The fiscal quarters ended October 28, 2023 and October 29, 2022 refer to the thirteen weeks ended as of those dates. The year-to-date periods ended October 28, 2023 and October 29, 2022 refer to the thirty-nine weeks ended as of those dates.
	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.91pt">Use of Estimates</span><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements requires management of the Company to make estimates and assumptions that affect the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the carrying amount of property and equipment, net realizable value for inventories, income taxes, share-based compensation expense, the incremental borrowing rate utilized in operating lease liabilities, equity method investments and notes receivable.</span></div>
CY2023Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	66845000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	usd
CY2023Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	292000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	66553000	usd
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	72722000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	813000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	71909000	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	31100000	usd
CY2023Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	25900000	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	27600000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	109700000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	104700000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	85500000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	50300000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	43600000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	43400000	usd
CY2023Q4	five	Deferred Compensation Arrangement With Individual Percent Of Eligible Compensation DeferredCompensationArrangementWithIndividualPercentOfEligibleCompensation	0.80
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	14594000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	16146000	usd
	us-gaap	Net Income Loss NetIncomeLoss	98907000	usd
	us-gaap	Net Income Loss NetIncomeLoss	90208000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	736405000	usd
CY2023Q4	five	Net Sales As Percentage Of Net Sales NetSalesAsPercentageOfNetSales	1.000
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	645034000	usd
CY2022Q4	five	Net Sales As Percentage Of Net Sales NetSalesAsPercentageOfNetSales	1.000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2221633000	usd
	five	Net Sales As Percentage Of Net Sales NetSalesAsPercentageOfNetSales	1.000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1953557000	usd
	five	Net Sales As Percentage Of Net Sales NetSalesAsPercentageOfNetSales	1.000
CY2023Q4	five	Number Of Leases NumberOfLeases	69	lease
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2023Q4	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	126600000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y8M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.052
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.052
CY2023Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	69298000	usd
CY2022Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	59401000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	196725000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	171080000	usd
CY2023Q4	us-gaap	Variable Lease Cost VariableLeaseCost	19435000	usd
CY2022Q4	us-gaap	Variable Lease Cost VariableLeaseCost	16012000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	56181000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	46134000	usd
CY2023Q4	us-gaap	Lease Cost LeaseCost	88733000	usd
CY2022Q4	us-gaap	Lease Cost LeaseCost	75413000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	77974000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	300247000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	287065000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	272970000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	251272000	usd
CY2023Q4	five	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	833838000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55452533	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55509525	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55592536	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55551382	shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	123607	shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	174084	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	125451	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	169410	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55576140	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55683609	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55717987	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55720792	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.78
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2023Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	5300000	usd
	five	Stock Option Maximum Term StockOptionMaximumTerm	P10Y
	five	Stock Option Vesting Period StockOptionVestingPeriod	P4Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18026	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34920
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	100	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	41.67
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	7800	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	36.70
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10126	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	33.48
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10126	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	33.48
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y9M18D
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	39900000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2018Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	usd
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	368699	shares
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	60000000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	162.75
CY2023	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	247132	shares
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	40000000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	161.88
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	usd
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	504369	shares
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	80000000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	158.63
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	1600000	shares
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	230000000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19557000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21417000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	128552000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	119615000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4963000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5271000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29645000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29407000	usd
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.254
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.246
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.231
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.246
CY2022Q4	five	Accrualforuncertaintaxinterestorpenalties Accrualforuncertaintaxinterestorpenalties	0	usd
CY2021Q4	five	Accrualforuncertaintaxinterestorpenalties Accrualforuncertaintaxinterestorpenalties	0	usd
CY2023Q4	five	Accrualforuncertaintaxinterestorpenalties Accrualforuncertaintaxinterestorpenalties	0	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001177609-23-000028-index-headers.html	Edgar Link	pending
0001177609-23-000028-index.html	Edgar Link	pending
0001177609-23-000028.txt	Edgar Link	pending
0001177609-23-000028-xbrl.zip	Edgar Link	pending
amendedandrestatedfivebelo.htm	Edgar Link	pending
compensationpolicyfornon-e.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
five-20231028.htm	Edgar Link	pending
five-20231028.xsd	Edgar Link	pending
fivebelowincdodd-frankclaw.htm	Edgar Link	pending
form10q_q32023fiveex311.htm	Edgar Link	pending
form10q_q32023fiveex312.htm	Edgar Link	pending
form10q_q32023fiveex321.htm	Edgar Link	pending
form10q_q32023fiveex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
five-20231028_cal.xml	Edgar Link	unprocessable
five-20231028_lab.xml	Edgar Link	unprocessable
five-20231028_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
five-20231028_pre.xml	Edgar Link	unprocessable
five-20231028_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FIVE
FIVE BELOW, INC Stock $five

2023 Q4 Form 10-Q Financial Statement

#000117760923000028 Filed on November 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FIVE FIVE BELOW, INC Stock $five

2023 Q4 Form 10-Q Financial Statement

#000117760923000028 Filed on November 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FIVE
FIVE BELOW, INC Stock $five